Pancreatic Cancer Research

ResearcherSahlgrenska University HospitalNo recent work listed

Lisa M. Nilsson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5222-7210; OpenAlex author ID A5086298459. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models. Co-author DOI 10.1016/j.gastha.2022.07.006↗
  2. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Co-author DOI 10.1136/gutjnl-2018-317856↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jonas A. Nilsson · 2 shared papers, 2020–2022 · strength 0.24
  2. Johan Bourghardt Fagman · 1 shared paper, 2022 · strength 0.16
  3. Christian Schneeweis · 1 shared paper, 2020 · strength 0.08
  4. Wilko Weichert · 1 shared paper, 2020 · strength 0.08
  5. Alexander Muckenhuber · 1 shared paper, 2020 · strength 0.08
  6. Felix Orben · 1 shared paper, 2020 · strength 0.08
  7. Zahra Dantes · 1 shared paper, 2020 · strength 0.08
  8. Zonera Hassan · 1 shared paper, 2020 · strength 0.08
  9. Ulrich Bernd Keller · 1 shared paper, 2020 · strength 0.08
  10. Maximilian Reichert · 1 shared paper, 2020 · strength 0.08
  11. Alexander Biederstädt · 1 shared paper, 2020 · strength 0.08
  12. Roland Rad · 1 shared paper, 2020 · strength 0.08
  13. Günter Schneider · 1 shared paper, 2020 · strength 0.08
  14. Matthias Wirth · 1 shared paper, 2020 · strength 0.08
  15. Dieter Saur · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.